Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Nov;119(6):1262–1268. doi: 10.1111/j.1476-5381.1996.tb16031.x

Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits.

A el-Hashim 1, B D'Agostino 1, M G Matera 1, C Page 1
PMCID: PMC1915904  PMID: 8937732

Abstract

1. Recent work has suggested that adenosine may be involved in asthma via the activation of A1 receptors. However, the role of the recently cloned A3 receptor in airways is largely unknown. In the present study, we have investigated the role of the A3 receptor in adenosine-induced bronchoconstriction in allergic rabbits. 2. Aerosol challenge of antigen (Ag) immunized rabbits with the adenosine precursor, adenosine 5'-monophosphate (AMP), resulted in a dose-dependent fall in dynamic compliance (Cdyn). The maximum fall in Cdyn in these rabbits was significantly greater than that in litter matched, sham immunized animals (P < 0.05). However, there was no significant difference in the maximum increase in airways resistance (Rt) between Ag and sham immunized rabbits (P > 0.05). 3. Aerosol challenge of Ag immunized rabbits with cyclopentyl-adenosine (CPA) (A1-receptor agonist) elicited a dose-dependent fall in Cdyn in Ag immunized rabbits and the maximum fall in Cdyn in these rabbits was significantly greater than that observed in sham immunized rabbits (P < 0.05). Similarly, CPA induced dose-dependent increases in R1 in Ag immunized rabbits whereas sham immunized rabbits failed to respond to CPA within the same dose range. The maximum increase in RL in Ag immunized rabbits was significantly greater than that of sham immunized rabbits (P < 0.05). 4. Aerosol challenge of either Ag or sham immunized rabbits with the A3 agonist aminophenylethyladenosine (APNEA) did not elicit dose-dependent changes in either RL or Cdyn. Moreover, there was no significant difference in the maximum response, measured by either parameter, between the two animal groups (P > 0.05). 5. These data provide further evidence for a role of the A1 receptor in the airways, but do not support a role for the A3 receptor in adenosine-induced bronchoconstriction in the allergic rabbit.

Full text

PDF
1262

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali H., Cunha-Melo J. R., Saul W. F., Beaven M. A. Activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen-stimulated RBL-2H3 cells. Evidence for a novel adenosine receptor. J Biol Chem. 1990 Jan 15;265(2):745–753. [PubMed] [Google Scholar]
  2. Ali S., Mustafa S. J., Metzger W. J. Adenosine receptor-mediated bronchoconstriction and bronchial hyperresponsiveness in allergic rabbit model. Am J Physiol. 1994 Mar;266(3 Pt 1):L271–L277. doi: 10.1152/ajplung.1994.266.3.L271. [DOI] [PubMed] [Google Scholar]
  3. Ali S., Mustafa S. J., Metzger W. J. Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor. J Pharmacol Exp Ther. 1994 Mar;268(3):1328–1334. [PubMed] [Google Scholar]
  4. Bai T. R., Lam R., Prasad F. Y. Effects of adrenergic agonists and adenosine on cholinergic neurotransmission in human tracheal smooth muscle. Pulm Pharmacol. 1989;1(4):193–199. doi: 10.1016/s0952-0600(89)80017-1. [DOI] [PubMed] [Google Scholar]
  5. Björck T., Gustafsson L. E., Dahlén S. E. Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis. 1992 May;145(5):1087–1091. doi: 10.1164/ajrccm/145.5.1087. [DOI] [PubMed] [Google Scholar]
  6. Brown C. M., Collis M. G. Evidence for an A2/Ra adenosine receptor in the guinea-pig trachea. Br J Pharmacol. 1982 Jul;76(3):381–387. doi: 10.1111/j.1476-5381.1982.tb09231.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Church M. K., Holgate S. T., Hughes P. J. Adenosine inhibits and potentiates IgE-dependent histamine release from human basophils by an A2-receptor mediated mechanism. Br J Pharmacol. 1983 Dec;80(4):719–726. doi: 10.1111/j.1476-5381.1983.tb10063.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Church M. K., Hughes P. J., Vardey C. J. Studies on the receptor mediating cyclic AMP-independent enhancement by adenosine of IgE-dependent mediator release from rat mast cells. Br J Pharmacol. 1986 Jan;87(1):233–242. doi: 10.1111/j.1476-5381.1986.tb10176.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cockcroft D. W., Ruffin R. E., Dolovich J., Hargreave F. E. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy. 1977 Nov;7(6):503–513. doi: 10.1111/j.1365-2222.1977.tb01481.x. [DOI] [PubMed] [Google Scholar]
  10. Collis M. G., Hourani S. M. Adenosine receptor subtypes. Trends Pharmacol Sci. 1993 Oct;14(10):360–366. doi: 10.1016/0165-6147(93)90094-z. [DOI] [PubMed] [Google Scholar]
  11. Coyle A. J., Page C. P., Atkinson L., Sjoerdsma K., Touvay C., Metzger W. J. Modification of allergen-induced airway obstruction and airway hyperresponsiveness in an allergic rabbit model by the selective platelet-activating factor antagonist, BN 52021. J Allergy Clin Immunol. 1989 Dec;84(6 Pt 1):960–967. doi: 10.1016/0091-6749(89)90395-3. [DOI] [PubMed] [Google Scholar]
  12. Crimi N., Palermo F., Oliveri R., Maccarrone C., Palermo B., Vancheri C., Polosa R., Mistretta A. Enhancing effect of dipyridamole inhalation on adenosine-induced bronchospasm in asthmatic patients. Allergy. 1988 Apr;43(3):179–183. doi: 10.1111/j.1398-9995.1988.tb00416.x. [DOI] [PubMed] [Google Scholar]
  13. Crimi N., Palermo F., Oliveri R., Polosa R., Settinieri I., Mistretta A. Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma. Eur Respir J. 1992 May;5(5):560–565. [PubMed] [Google Scholar]
  14. Cushley M. J., Tattersfield A. E., Holgate S. T. Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. Am Rev Respir Dis. 1984 Mar;129(3):380–384. doi: 10.1164/arrd.1984.129.3.380. [DOI] [PubMed] [Google Scholar]
  15. Cushley M. J., Tattersfield A. E., Holgate S. T. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol. 1983 Feb;15(2):161–165. doi: 10.1111/j.1365-2125.1983.tb01481.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Feoktistov I., Biaggioni I. Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest. 1995 Oct;96(4):1979–1986. doi: 10.1172/JCI118245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Finney M. J., Karlsson J. A., Persson C. G. Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation. Br J Pharmacol. 1985 May;85(1):29–36. doi: 10.1111/j.1476-5381.1985.tb08827.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fozard J. R., Pfannkuche H. J., Schuurman H. J. Mast cell degranulation following adenosine A3 receptor activation in rats. Eur J Pharmacol. 1996 Mar 18;298(3):293–297. doi: 10.1016/0014-2999(95)00822-5. [DOI] [PubMed] [Google Scholar]
  19. Fuller R. W., Dixon C. M., Cuss F. M., Barnes P. J. Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis. 1987 Jan;135(1):176–180. doi: 10.1164/arrd.1987.135.1.176. [DOI] [PubMed] [Google Scholar]
  20. Gilfillan A. M., Rooney S. A. Functional evidence for adenosine A2 receptor regulation of phosphatidylcholine secretion in cultured type II pneumocytes. J Pharmacol Exp Ther. 1987 Jun;241(3):907–914. [PubMed] [Google Scholar]
  21. Ginsborg B. L., Hirst G. D. The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat. J Physiol. 1972 Aug;224(3):629–645. doi: 10.1113/jphysiol.1972.sp009916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Grundström N., Andersson R. G., Wikberg J. E. Investigations on possible presynaptic effect of adenosine and noradrenaline on cholinergic neurotransmission in guinea pig trachea. Acta Pharmacol Toxicol (Copenh) 1981 Aug;49(2):158–160. doi: 10.1111/j.1600-0773.1981.tb00885.x. [DOI] [PubMed] [Google Scholar]
  23. Gustafsson L. E., Wiklund N. P., Cederqvist B. Apparent enhancement of cholinergic transmission in rabbit bronchi via adenosine A2 receptors. Eur J Pharmacol. 1986 Jan 21;120(2):179–185. doi: 10.1016/0014-2999(86)90538-8. [DOI] [PubMed] [Google Scholar]
  24. Hannon J. P., Pfannkuche H. J., Fozard J. R. A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat. Br J Pharmacol. 1995 Jul;115(6):945–952. doi: 10.1111/j.1476-5381.1995.tb15902.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hughes P. J., Holgate S. T., Church M. K. Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem Pharmacol. 1984 Dec 1;33(23):3847–3852. doi: 10.1016/0006-2952(84)90050-9. [DOI] [PubMed] [Google Scholar]
  26. Jacobson K. A., van Galen P. J., Williams M. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem. 1992 Feb 7;35(3):407–422. doi: 10.1021/jm00081a001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Londos C., Cooper D. M., Wolff J. Subclasses of external adenosine receptors. Proc Natl Acad Sci U S A. 1980 May;77(5):2551–2554. doi: 10.1073/pnas.77.5.2551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lundblad K. A., Persson C. G. The epithelium and the pharmacology of guinea-pig tracheal tone in vitro. Br J Pharmacol. 1988 Apr;93(4):909–917. doi: 10.1111/j.1476-5381.1988.tb11479.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mann J. S., Cushley M. J., Holgate S. T. Adenosine-induced bronchoconstriction in asthma. Role of parasympathetic stimulation and adrenergic inhibition. Am Rev Respir Dis. 1985 Jul;132(1):1–6. doi: 10.1164/arrd.1985.132.1.1. [DOI] [PubMed] [Google Scholar]
  30. Minshall E. M., Riccio M. M., Herd C. M., Douglas G. J., Seeds E. A., McKenniff M. G., Sasaki M., Spina D., Page C. P. A novel animal model for investigating persistent airway hyperresponsiveness. J Pharmacol Toxicol Methods. 1993 Dec;30(4):177–188. doi: 10.1016/1056-8719(93)90015-7. [DOI] [PubMed] [Google Scholar]
  31. Minshall E., Spina D., Page C. P. Effects of neonatal immunization and repeated allergen exposure on airway responsiveness in the rabbit. J Appl Physiol (1985) 1996 Jun;80(6):2108–2119. doi: 10.1152/jappl.1996.80.6.2108. [DOI] [PubMed] [Google Scholar]
  32. Negri L., Lattanzi R., Melchiorri P. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors. Br J Pharmacol. 1995 Jan;114(1):57–66. doi: 10.1111/j.1476-5381.1995.tb14905.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Phillips G. D., Ng W. H., Church M. K., Holgate S. T. The response of plasma histamine to bronchoprovocation with methacholine, adenosine 5'-monophosphate, and allergen in atopic nonasthmatic subjects. Am Rev Respir Dis. 1990 Jan;141(1):9–13. doi: 10.1164/ajrccm/141.1.9. [DOI] [PubMed] [Google Scholar]
  34. Polosa R., Holgate S. T., Church M. K. Adenosine as a pro-inflammatory mediator in asthma. Pulm Pharmacol. 1989;2(1):21–26. doi: 10.1016/s0952-0600(89)80005-5. [DOI] [PubMed] [Google Scholar]
  35. Polosa R., Ng W. H., Crimi N., Vancheri C., Holgate S. T., Church M. K., Mistretta A. Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):624–629. doi: 10.1164/ajrccm/151.3_Pt_1.624. [DOI] [PubMed] [Google Scholar]
  36. Polosa R., Rajakulasingam K., Church M. K., Holgate S. T. Repeated inhalation of bradykinin attenuates adenosine 5'-monophosphate (AMP) induced bronchoconstriction in asthmatic airways. Eur Respir J. 1992 Jun;5(6):700–706. [PubMed] [Google Scholar]
  37. Ramkumar V., Stiles G. L., Beaven M. A., Ali H. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem. 1993 Aug 15;268(23):16887–16890. [PubMed] [Google Scholar]
  38. Ribeiro J. A., Sebastião A. M. Further evidence for adenosine A3 receptors. Trends Pharmacol Sci. 1994 Jan;15(1):13–14. doi: 10.1016/0165-6147(94)90123-6. [DOI] [PubMed] [Google Scholar]
  39. Shampain M. P., Behrens B. L., Larsen G. L., Henson P. M. An animal model of late pulmonary responses to Alternaria challenge. Am Rev Respir Dis. 1982 Sep;126(3):493–498. doi: 10.1164/arrd.1982.126.3.493. [DOI] [PubMed] [Google Scholar]
  40. Sterk P. J., Bel E. H. The shape of the dose-response curve to inhaled bronchoconstrictor agents in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991 Jun;143(6):1433–1437. doi: 10.1164/ajrccm/143.6.1433. [DOI] [PubMed] [Google Scholar]
  41. Woolcock A. J., Salome C. M., Yan K. The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis. 1984 Jul;130(1):71–75. doi: 10.1164/arrd.1984.130.1.71. [DOI] [PubMed] [Google Scholar]
  42. Zhou Q. Y., Li C., Olah M. E., Johnson R. A., Stiles G. L., Civelli O. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7432–7436. doi: 10.1073/pnas.89.16.7432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. van Calker D., Müller M., Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem. 1979 Nov;33(5):999–1005. doi: 10.1111/j.1471-4159.1979.tb05236.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES